Xu YN - Search Results

1

[Current situation and demand for specialized development of allergy nursing in eighty-eight hospitals in Guangdong Province].

Dai C, Su J, Xu YL, Chen QP, Lin XX, Xu YN, Liu XL, Chen S, Xu YX, Yan AZ, Hu YY, Wang L, Yan FF, Zhou QL. Dai C, et al. Among authors: xu yn. Zhonghua Yu Fang Yi Xue Za Zhi. 2024 Dec 6;58(12):1926-1932. doi: 10.3760/cma.j.cn112150-20240125-00084. Zhonghua Yu Fang Yi Xue Za Zhi. 2024. PMID: 39710471 Chinese.

2

[High-grade endometrial carcinoma with choriocarcinoma differentiation: report of a case].

Xu JC, Xu Y, Li KD, Wang C. Xu JC, et al. Zhonghua Bing Li Xue Za Zhi. 2022 Nov 8;51(11):1180-1183. doi: 10.3760/cma.j.cn112151-20220826-00732. Zhonghua Bing Li Xue Za Zhi. 2022. PMID: 36323555 Chinese.

3

[Cardiac metastasis of ependymoma: report of a case].

Han J, Gao XZ, Xu Y, Du Q, Li SL. Han J, et al. Zhonghua Bing Li Xue Za Zhi. 2023 Feb 8;52(2):181-183. doi: 10.3760/cma.j.cn112151-20220527-00463. Zhonghua Bing Li Xue Za Zhi. 2023. PMID: 36748144 Chinese.

4

[Preliminary clinical application of novel magnetic navigation and ultrasound-guided percutaneous transhepatic cholangiography drainage through the right liver duct for malignant obstructive jaundice].

Zhuo H, Wu C, Tan ZM, Tang WW, Zhu DM, Xu Y, Zhao J, Gu JP, Wang XH, Song JH. Zhuo H, et al. Zhonghua Nei Ke Za Zhi. 2024 Mar 1;63(3):284-290. doi: 10.3760/cma.j.cn112138-20231031-00270. Zhonghua Nei Ke Za Zhi. 2024. PMID: 38448192 Clinical Trial. Chinese.

5

[Validation of the prognostic value of the Mayo MASS and R2-ISS staging systems in patients newly diagnosed with multiple myeloma: A single-center study].

Xu Y, Shen XX, Jin YY, Li JY, Chen LJ, Zhang R. Xu Y, et al. Zhonghua Xue Ye Xue Za Zhi. 2023 Sep 14;44(9):749-754. doi: 10.3760/cma.j.issn.0253-2727.2023.09.008. Zhonghua Xue Ye Xue Za Zhi. 2023. PMID: 38049319 Free PMC article. Chinese.

6

[Isolated myeloid sarcoma of the cervix: a clinicopathological analysis of three cases].

Xu C, Wang Z, Xu Y, Wang C. Xu C, et al. Zhonghua Bing Li Xue Za Zhi. 2022 Nov 8;51(11):1164-1166. doi: 10.3760/cma.j.cn112151-20220825-00725. Zhonghua Bing Li Xue Za Zhi. 2022. PMID: 36323550 Chinese.

7

[Ovarian myxoma and sclerosing stromal tumor: report of a case].

Meng ZQ, Yan SP, Xu Y, Chen KS. Meng ZQ, et al. Zhonghua Bing Li Xue Za Zhi. 2023 Nov 8;52(11):1177-1179. doi: 10.3760/cma.j.cn112151-20230304-00171. Zhonghua Bing Li Xue Za Zhi. 2023. PMID: 37899331 Chinese.

8

Case Report: Pathogenesis With a Rare RHOA A161E Mutation in a Patient With Angioimmunoblastic T-Cell Lymphoma.

Cao L, Tong H, Liu X, Xu Y, Yu F, Pan Q, Lai J, Huang J, Qin J, Jin J. Cao L, et al. Front Genet. 2022 Jul 14;13:948744. doi: 10.3389/fgene.2022.948744. eCollection 2022. Front Genet. 2022. PMID: 35910204 Free PMC article.

9

[Efficacy analysis of selinexor combined with hypomethylating agent in the treatment of refractory/relapsed acute myeloid leukemia exposed to venetoclax].

Zhang J, Song BQ, Kong X, Liu Y, Yang HL, Zong LH, Kong JY, Xu Y, Qiu HY, Wu DP. Zhang J, et al. Zhonghua Xue Ye Xue Za Zhi. 2023 Nov 14;44(11):936-939. doi: 10.3760/cma.j.issn.0253-2727.2023.11.009. Zhonghua Xue Ye Xue Za Zhi. 2023. PMID: 38185524 Free PMC article. Chinese. No abstract available.

10

Eosinophilia in a patient with aggressive systemic mastocytosis harboring a KIT D816V mutation: A case report.

Cao L, Tong H, Liu X, Pan Q, Xu Y, Lai J, Zheng W, Huang J, Wang Z, Ye S, Zhang L, Qin J, Jin J. Cao L, et al. SAGE Open Med Case Rep. 2023 Aug 30;11:2050313X231197322. doi: 10.1177/2050313X231197322. eCollection 2023. SAGE Open Med Case Rep. 2023. PMID: 37663152 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

297 results

Search Page

Filters